8/21/2017 - Breakthroughs in Antibody Desensitization Therapy

What are antibodies? How do they contribute to transplant rejection? How do they block your access to the kidney transplant list? What can be done to manage antibodies? Stanley C. Jordan, MD, Director of Nephrology & Transplant Immunology at Cedars-Sinai Medical Center, a pioneering kidney transplant researcher, who has received the International Society of Nephrology's highest honor for groundbreaking work that improves the lives of kidney transplant patients while preserving the precious resource of donated organs has answered many of the questions. Listen in to hear about his research to reduce organ rejection, breakthroughs in antibody desensitization therapy and other advances in transplantation.